Listen to this article


The US Senate has signed off on US President Donald Trump’s pick to head the US Food and Drug Administration, a federal agency that oversees consumer products ranging from medical drugs and devices to food, cosmetics and tobacco.

Senators voted 57-42 to confirm Scott Gottlieb, a physician and regulator whose selection was welcomed by the pharmaceuticals sector — and whose ties to that industry were questioned by Democrats.

Dr Gottlieb served as a deputy commissioner of the FDA during the George W Bush administration and has held several roles in the drug industry, including as a venture capitalist and director or advisor for several large drugmakers including GlaxoSmithKline.

Copyright The Financial Times Limited 2017. All rights reserved.

Follow the topics mentioned in this article

Follow the authors of this article

Comments have not been enabled for this article.